Skip to main content
Contact Us
Subscribe
E-Edition
58°
Site search
Search
Menu
Open user controls
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
Home
About Us
Contact Us
Advertise
Terms and Conditions
Privacy Policy
Home Delivery
Subscription Services
Place an Ad
Promote Your Event
Local Weather
News
Sports
Obits
Multimedia
Photo Galleries
Videos
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Subscribe
Best of 2024
Archives
2025 Calendar Photos
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Latest News about REGN
Recent news which mentions REGN
< Previous
1
2
...
23
24
25
26
27
28
29
30
Next >
A Deep Dive Into COVID Oral Treatments — What Does the Atea Failure Mean for Oral Antivirals?
November 05, 2021
Tickers
ADMP
AVIR
GILD
LLY
Tags
Partner Content
Small Cap
General
From
Benzinga
Wall Street Crime and Punishment: Martin Shkreli, The Self-Destructive Pharma Bro
November 05, 2021
Tickers
MNKD
NAVB
REGN
Tags
News
Health Care
pharmaceuticals
From
Benzinga
What 8 Analyst Ratings Have To Say About Regeneron Pharmaceuticals
November 05, 2021
Tickers
REGN
Tags
BZI/AAR
Analyst Ratings
REGN
From
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For November 5, 2021
November 05, 2021
Tickers
APO
BCE
BGS
BIGC
Tags
Market News
SKT
NPTN
From
Benzinga
A Deep Dive Into COVID Oral Treatments — What Does the Atea Failure Mean for Oral Antivirals?
November 05, 2021
Tickers
ADMP
AVIR
GILD
LLY
Tags
MRK
ADMP
GILD
From
Benzinga
3 Reasons Why Investors Should Love Regeneron's Q3 Update
November 05, 2021
Tickers
REGN
Tags
Recent Press Releases
Market News
REGN
From
Motley Fool
Regeneron Pharmaceuticals Inc (REGN) Q3 2021 Earnings Call Transcript
November 04, 2021
Tickers
REGN
Tags
Recent Press Releases
Market News
REGN
From
Motley Fool
7 European Stocks to Buy to Diversify Your Portfolio
November 04, 2021
Tickers
AFLYY
ASML
LRLCF
LVMUY
Tags
RHHBY
AFLYY
NXPI
From
InvestorPlace
Regeneron Pharmaceuticals Earnings Perspective: Return On Invested Capital
November 04, 2021
Tickers
REGN
Tags
Market News
Benzinga
Earnings
From
Benzinga
Why Regeneron Shares Are Rising Today
November 04, 2021
Tickers
REGN
Tags
Benzinga
Earnings
News
From
Benzinga
The Daily Biotech Pulse: Merck's Oral COVID-19 Pill Authorized In UK, Novartis Cashes Out Of Roche, Chimerix Plunges On Data, Evotec IPO
November 04, 2021
Tickers
AERI
ALGS
ALLO
ANIP
Tags
VERA
Small Cap
OYST
From
Benzinga
Is There Any Hope for Atea Pharmaceuticals Stock?
November 04, 2021
Tickers
AVIR
GILD
MRK
REGN
Tags
Recent Press Releases
AVIR
REGN
From
Motley Fool
Healthcare Stocks Subject to Government Policy
November 02, 2021
Tickers
ABBV
AMGN
BIIB
BNTX
Tags
Partner Content
DD
ABBV
From
Benzinga
A Pfizer Drug Moves Closer to Approval in Another Important Indication
November 02, 2021
Tickers
BNTX
PFE
REGN
SNY
Tags
BNTX
Market News
REGN
From
Motley Fool
The Week Ahead In Biotech (Oct. 31-Nov. 6): Earnings Pick Up Pace, Eton Awaits Seizure Drug Approval, Kidney Conference, More IPOs In The Pipeline
October 31, 2021
Tickers
ADPT
AERI
AGIO
ALGS
Tags
ICUI
DRNA
CORT
From
Benzinga
The Daily Biotech Pulse: Gilead-Merck Collaborate For Breast Cancer Study, Decision Day For ANI Pharma, Pfizer Gets Canadian Regulatory Nod, 3 IPOs
October 29, 2021
Tickers
A
ABBV
ABIO
ANIP
Tags
Offerings
GILD
IRMD
From
Benzinga
Will Regeneron Be Worth More Than Amazon by 2030?
October 28, 2021
Tickers
AMZN
BNTX
MRNA
REGN
Tags
MRNA
BNTX
Market News
From
Motley Fool
1 Small-Cap Stock With 10X Potential
October 27, 2021
Tickers
GILD
NRXP
REGN
Tags
REGN
RLFT/F
NRXP
From
Motley Fool
Where Regeneron Pharmaceuticals Stands With Analysts
October 26, 2021
Tickers
REGN
Tags
Market News
Benzinga
Analyst Ratings
From
Benzinga
The Week Ahead In Biotech (Oct. 24-30): Eyenovia, ANI Pharma, Clearside Medical FDA Decisions, Merck, Bristol-Myers Squibb Earnings, IPOs And More
October 24, 2021
Tickers
ABBV
ADAP
ALIM
ALKS
Tags
TARO
Small Cap
GNCA
From
Benzinga
Can AstraZeneca's COVID Antibody Therapy Win Against Regeneron and Eli Lilly?
October 23, 2021
Tickers
AZN
GSK
JNJ
LLY
Tags
VIR
AZN
Market News
From
Motley Fool
The Daily Biotech Pulse: Athira CEO Resigns Over Doctored Research, Merck's Keytruda Snags First Approval For Breast Cancer In Europe, Minerva And Xilio IPOs
October 22, 2021
Tickers
ADPT
ATHA
AVRO
IBB
Tags
SNY
JNJ
TTOO
From
Benzinga
Biotech Buyouts That Would Be Great for Investors
October 22, 2021
Tickers
CRSP
NTLA
REGN
VRTX
Tags
REGN
NTLA
Market News
From
Motley Fool
Will Merck's COVID-19 Pill Sink Regeneron's and Eli Lilly's Antibody Therapy Sales?
October 22, 2021
Tickers
AZN
LLY
MRK
REGN
Tags
REGN
AZN
MRK
From
Motley Fool
The Daily Biotech Pulse: FDA Authorizes Moderna, J&J Booster Shots; Regulatory Approvals For Bristol-Myers Squibb, Sanofi-Regeneron; Ventyx IPO
October 21, 2021
Tickers
ABEO
ADMA
BHC
BMY
Tags
General
Small Cap
IPOs
From
Benzinga
Esperion Chops 40% Workforce As Launch Of Cholesterol Medication Falters
October 18, 2021
Tickers
AMGN
DSKYF
DSNKY
ESPR
Tags
Market News
Earnings
Trading Ideas
From
Benzinga
The Week Ahead In Biotech (Oct. 18-23): J&J, Biogen Kickstart Big Pharma Earnings, Regeneron-Sanofi, Roche Await FDA Decisions And IPOs
October 18, 2021
Tickers
ABEO
ABT
AVDL
AVRO
Tags
ABEO
MRNA
PTGX
From
Benzinga
2 Best Biotech Stocks to Buy Right Now
October 18, 2021
Tickers
ABBV
AMGN
AZN
BMY
Tags
ABBV
AMGN
JNJ
From
Motley Fool
3 No-Brainer Biotech Stocks to Buy Right Now
October 16, 2021
Tickers
CRSP
PFE
REGN
SNY
Tags
VRTX
CRSP
REGN
From
Motley Fool
Why Shares of Allogene Therapeutics, Beam Therapeutics, Intellia Therapeutics, and Schrödinger Are Volatile This Week
October 15, 2021
Tickers
ALLO
BEAM
CRSP
NTLA
Tags
Market News
BEAM
SDGR
From
Motley Fool
< Previous
1
2
...
23
24
25
26
27
28
29
30
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.